AD-I Bubble CPAP
The AD-I Bubble CPAP, namely continuous positive airway pressure system, is a professional pediatric respiratory support medical device independently developed and manufactured to meet the growing clinical demand for non-invasive respiratory intervention in pediatrics. Rooted in the widespread and mature application of non-invasive continuous positive airway pressure technology in the global pediatric medical field, this medical equipment is engineered with targeted optimization for the physiological characteristics of young pediatric patients, filling the demand gap of safe, efficient and gentle respiratory auxiliary treatment for children of different age groups.
This device has a clear and standardized applicable population, covering premature infants with immature respiratory development, full-term newborns, common infants and young children, as well as children up to 14 years old. Such a wide age coverage enables the AD-I Bubble CPAP to adapt to the respiratory treatment needs of pediatric patients at various growth stages, making it a versatile medical device for pediatric pulmonology, neonatal intensive care units and general pediatric wards. Clinically, it is mainly applied to nasal congestion CPAP ventilation treatment, which serves as a core non-invasive ventilation method for pediatric respiratory diseases.
One of the core advantages of the AD-I Bubble CPAP is its capability to effectively reduce children's work of breathing. During the onset of respiratory diseases such as neonatal respiratory distress syndrome, mild pulmonary infection and nasal congestion hypoxia, pediatric patients need to consume extra physical strength to overcome airway resistance and alveolar collapse, which will lead to increased breathing load, fatigue of respiratory muscles, and even aggravation of hypoxia symptoms in severe cases. By continuously delivering stable positive pressure to the nasal cavity and airway, the device can prop open the collapsed alveoli, reduce airway resistance, and balance the pressure inside and outside the respiratory tract. This significantly lowers the energy consumption required for each breath, relieves respiratory muscle fatigue, and greatly improves the breathing comfort of young patients.
Superiority
Able to provide a controllable oxygen concentration for babies
Able to maintain functional residual capacity
Can help reduce the work of breathing done by babies
Can reduce the need for invasive mechanical ventilation
Able to provide warm and humid air to babies
Can reduce the incidence of chronic pneumonia ( CLD )
Can improve some lung physiological indicators, such as height, weight, etc.